Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tharimmune, Inc. - Common Stock
(NQ:
THAR
)
4.740
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tharimmune, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Unusual volume stocks in Thursday's session
↗
August 21, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via
Chartmill
Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session.
↗
August 21, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
August 21, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
These stocks that are showing activity before the opening bell on Thursday.
↗
August 21, 2025
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 21, 2025
Via
Benzinga
Stock Market Today: Dow, S&P 500 Futures Slip As Jackson Hole Kicks Off— Walmart, Intuit, Ross Stores Earnings In Focus
↗
August 21, 2025
U.S. stock futures were slightly below the flatline on Thursday following Wednesday's mixed close. Futures were lower.
Via
Benzinga
Topics
Stocks
Why Nordson Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
↗
August 21, 2025
Via
Benzinga
Tharimmune Rockets 42% After Hours — Adding To Stunning 206% Daytime Rally: What's Going On?
↗
August 21, 2025
Tharimmune soared over 42% after hours Wednesday after reporting strong data for its opioid overdose prevention drug.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 20, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
↗
August 20, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 20, 2025
Via
Benzinga
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments
August 20, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
August 13, 2025
Via
Benzinga
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl
August 13, 2025
Via
ACCESS Newswire
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors
August 05, 2025
Via
ACCESS Newswire
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery
August 04, 2025
Via
ACCESS Newswire
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants
July 23, 2025
Via
ACCESS Newswire
Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors
June 17, 2025
Via
ACCESS Newswire
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
May 19, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 06, 2025
Via
Benzinga
Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
May 06, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 02, 2025
Via
Benzinga
Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences
May 01, 2025
Via
ACCESS Newswire
Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors
April 30, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 28, 2025
Via
Benzinga
Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
April 28, 2025
Via
ACCESS Newswire
Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors
April 15, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 07, 2025
Via
Benzinga
Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
April 07, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
